FITC Anti-Candida albicans antibody (ab21164)
Key features and details
- FITC Rabbit polyclonal to Candida albicans
- Suitable for: Double Immunodiffusion, Counter Current Immunoelectrophoresis, ICC/IF, ELISA
- Conjugation: FITC. Ex: 493nm, Em: 528nm
- Isotype: IgG
Overview
-
Product name
FITC Anti-Candida albicans antibody
See all Candida albicans primary antibodies -
Description
FITC Rabbit polyclonal to Candida albicans -
Host species
Rabbit -
Conjugation
FITC. Ex: 493nm, Em: 528nm -
Specificity
Recognizes numerous proteins in a soluble C. albicans extract (IEP). Has not been absorbed and does cross-react with other yeasts. Negative against human serum, urine and spinal fluid. -
Tested applications
Suitable for: Double Immunodiffusion, Counter Current Immunoelectrophoresis, ICC/IF, ELISAmore details -
Species reactivity
Has not been absorbed and does react with other yeasts. -
Immunogen
Candida albicans, type A (ATCC #32354).
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
Preservative: 0.1% Sodium azide
Constituents: 0.0268% PBS, 1% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Purification notes
Protein A chromatography purified IgG fraction covalently coupled with high purity isomer I of fluorescein isothiocyanate. Care is taken to ensure complete removal of any free fluorescein from the final product. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Isotype control
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab21164 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Double Immunodiffusion |
Use at an assay dependent dilution.
|
|
Counter Current Immunoelectrophoresis |
Use at an assay dependent dilution.
|
|
ICC/IF |
Use at an assay dependent dilution.
|
|
ELISA |
Use at an assay dependent dilution.
|
Notes |
---|
Double Immunodiffusion
Use at an assay dependent dilution. |
Counter Current Immunoelectrophoresis
Use at an assay dependent dilution. |
ICC/IF
Use at an assay dependent dilution. |
ELISA
Use at an assay dependent dilution. |
Target
-
Relevance
Candida albicans is the most frequently isolated fungal pathogen of humans, affecting immunocompromised patients ranging from premature infants to AIDS sufferers. Systemic infections have an attributed mortality of 30-50%. C. albicans is a diploid organism which has eight sets of homologous chromosomes. It has a genome of approximately 16 Mb (haploid), about 30% greater than S. cerevisiae (baker’s yeast). -
Alternative names
- C albicans antibody
- Thrush antibody
Protocols
References (2)
ab21164 has been referenced in 2 publications.
- Wurster S et al. Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module. mBio 10:N/A (2019). PubMed: 31138745
- Drummond RA et al. CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System. PLoS Pathog 11:e1005293 (2015). Flow Cyt ; Human . PubMed: 26679537